Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p189
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 189/312)
Character Range: 16651137–16659134

(iii) being assessed for correct inhaler technique.
                                                                                                                           Patient must be at least 18 years of age.
                                                                                                                           Optimised asthma therapy includes adherence to the maintenance combination of an inhaled corticosteroid (at least 800 micrograms budesonide per day or equivalent) and a long acting beta-2 agonist.
C15602              P15602         CN15602          Entacapone                                                             Parkinson disease
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           The treatment must be as adjunctive therapy to a levodopa-decarboxylase inhibitor combination; AND
                                                                                                                           Patient must be experiencing fluctuations in motor function due to end-of-dose effect.
C15604              P15604         CN15604          Fluticasone propionate with salmeterol                                 Asthma                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Compliance with Authority Required procedures - Streamlined Authority Code 15604
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           Patient must have previously had frequent episodes of asthma while receiving treatment with oral corticosteroids or optimal doses of inhaled corticosteroids.
                                                                                                                           Patient must be aged 4 years or older.
C15606              P15606         CN15606          Escitalopram                                                           Moderate to severe generalised anxiety disorder (GAD)
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           The condition must be defined by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria; AND
                                                                                                                           Patient must not have responded to non-pharmacological therapy; AND
                                                                                                                           Patient must be one for whom a GP Mental Health Care Plan, as described under items 2715 or 2717 of the Medicare Benefits Schedule, has been prepared.
C15607              P15607         CN15607          Formoterol                                                             Asthma
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                    Salmeterol                                                             Patient must experience frequent episodes of the condition; AND
                                                                                                                           Patient must be currently receiving treatment with oral corticosteroids; OR
                                                                                                                           Patient must be currently receiving treatment with optimal doses of inhaled corticosteroids.
C15608              P15608         CN15608          Levodopa with carbidopa                                                Parkinson disease
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           The condition must be one in which fluctuations in motor function are not adequately controlled by frequent dosing with conventional formulations of levodopa with decarboxylase inhibitor.
C15611              P15611         CN15611          Tiotropium                                                             Chronic obstructive pulmonary disease (COPD)
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.
C15615              P15615         CN15615          Budesonide with formoterol                                             Asthma                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Compliance with Authority Required procedures - Streamlined Authority Code 15615
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           Patient must have previously had frequent episodes of asthma while receiving treatment with